Tumor
164
31
41
68
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
68 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
10 terminated out of 164 trials
87.2%
+0.6% vs benchmark
5%
9 trials in Phase 3/4
21%
14 of 68 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 68 completed trials
Clinical Trials (164)
Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
68Ga-FAPI PET/CT in Patients With Various Types of Cancer
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Decoupling Immunotherapy Toxicity and Cancer Response
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
Evaluation of Proton Therapy in Pediatric Cancer Patients
New Models for the Evaluation of Preclinical Treatment for Urothelial Carcinomas of the Upper Excretory Tract.
SBRT-LATTICE-PATHY
A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
A Study of Live Tumor Fragments of Surgical Resections
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
The Needs and Burden of Family Caregivers of Older Adults With Cancer
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures